Cover Image
市場調查報告書

Cardioxyl Pharmaceuticals, Inc. :產品平台分析

Cardioxyl Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251748
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
Cardioxyl Pharmaceuticals, Inc. :產品平台分析 Cardioxyl Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年03月26日 內容資訊: 英文 20 Pages
簡介

Cardioxyl Pharmaceuticals, Inc.是臨床階段的生物製藥公司,尤其致力於循環系統疾病的治療藥開發,對現在還沒確立治療方法的疾病領域的新發現與開發,商品化也投入了力量。

本報告提供Cardioxyl Pharmaceuticals, Inc. 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、各分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Cardioxyl Pharmaceuticals, Inc.的基本資料

  • Cardioxyl Pharmaceuticals, Inc.概要
  • 主要資訊
  • 企業資料

Cardioxyl Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Cardioxyl Pharmaceuticals, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Cardioxyl Pharmaceuticals, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式

Cardioxyl Pharmaceuticals, Inc.:藥物簡介

  • CXL-1427
  • CXL-1036
  • Small Molecule for Pulmonary Arterial Hypertension

Cardioxyl Pharmaceuticals, Inc.:開發平台分析

  • 各給藥途徑
  • 各分子類型

Cardioxyl Pharmaceuticals, Inc.:最近的開發平台趨勢

Cardioxyl Pharmaceuticals, Inc.:暫停中的計劃

Cardioxyl Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06864CDB

Summary

Global Markets Direct's, 'Cardioxyl Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Cardioxyl Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Cardioxyl Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Cardioxyl Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Cardioxyl Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Cardioxyl Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Cardioxyl Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Cardioxyl Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Cardioxyl Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Cardioxyl Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cardioxyl Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Cardioxyl Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Cardioxyl Pharmaceuticals, Inc. Snapshot
    • Cardioxyl Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Cardioxyl Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Cardioxyl Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Cardioxyl Pharmaceuticals, Inc. - Pipeline Products Glance
    • Cardioxyl Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Cardioxyl Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Cardioxyl Pharmaceuticals, Inc. - Drug Profiles
    • CXL-1427
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CXL-1036
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Pulmonary Arterial Hypertension
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Cardioxyl Pharmaceuticals, Inc. - Pipeline Analysis
    • Cardioxyl Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Cardioxyl Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
  • Cardioxyl Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Cardioxyl Pharmaceuticals, Inc. - Dormant Projects
  • Cardioxyl Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Cardioxyl Pharmaceuticals, Inc., Key Information
  • Cardioxyl Pharmaceuticals, Inc., Key Facts
  • Cardioxyl Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Phase II, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Preclinical, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Dormant Developmental Projects,2015
  • Cardioxyl Pharmaceuticals, Inc., Other Locations

List of Figures

  • Cardioxyl Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Cardioxyl Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top